Ticker Details
VYNE Therapeutics Inc.
IPO Date:	January 22, 2018
Sector:	Healthcare
Market Cap:	$22.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 4.72%
Avg Daily Range (30 D):	$0.02 | 2.54%
Avg Daily Range (90 D):	$0.02 | 2.62%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.13M
Avg Daily Volume (90 D):	.17M

Trade Size
Avg Trade Size (Sh.):	168
Avg Trade Size (Sh.) (30 D):	579
Avg Trade Size (Sh.) (90 D):	602

Institutional Trades
Total Institutional Trades:	35
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$.55M
Avg Institutional Trade (90 D):	$.55M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.91M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	31.93K

News

Apr 1, 2026 @ 6:06 PM SHAREHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc

Dec 20, 2025 @ 4:26 PM Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB... Source: Halper Sadeh Llc

Dec 17, 2025 @ 1:00 PM VYNE Therapeutics and Yarrow Bioscience Announce M... Source: Not Specified

Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight

Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.49	$-.08
Diluted EPS	$-.49	$-.08
Revenue	$.45M	$.09M
Gross Profit
Net Income / Loss	$-21.46M	$-3.59M
Operating Income / Loss	$-24.37M	$-3.82M
Cost of Revenue
Net Cash Flow	$-3.58M	$.6M
PE Ratio

Splits
Feb 13, 2023	1:18
Feb 16, 2021	1:4